WebBritish pharmaceutical company GlaxoSmithKline (GSK) discovered this firsthand when, in 2014, the company was fined $489 million by Chinese courts for bribing doctors and hospitals to use its products and bribing government officials and regulators to ease monitoring of GSK. WebAs GSK bribery in China was a breach of US's Foreign Corrupt Practices Act during 2010–13, the Securities and Exchange Commission launched an investigation into the …
Glaxo’s China Scandal Exposes Big-Pharma’s Ugly Underworld
Web14 << July/August 2014 www.chinalawandpractice.com Cover story GSK: A case study GlaxoSmithKline is facing serious charges of misconduct as enforcement grows fierce. The entwining Chinese anti-bribery laws, the US FCPA and UK Bribery Act call for immediate attention to risks and compliance on both a national and global scale WebJul 3, 2014 · •July 2014 - China says Peter Humphrey and wife will be tried in secret. ... GSK has apologised to the Chinese authorities over the bribery scandal. ... What's behind GSK's China scandal? 1 July ... city of indianapolis recycling program
GSK: A case study - Davis Polk & Wardwell
WebIn another FT article, entitled “China steps up GSK bribery probe”, Andrew Jack and Leslie Hook reported that “The Chinese authorities have stepped up their investigation into GlaxoSmithKline accusing it of being the ringleader of a half-a-billion-dollar bribery scandal involving 700 companies.” WebGlaxoSmithKline in China – Ethical Issues Faced The moral issue under concern in this particular section is the company’s involvement in the act of bribery with the Chinese government and officials belonging from the pharmaceutical industry, which led to the company facing severe consequences. WebChina Fines GlaxoSmithKline Nearly $500 Million in Bribery Case. The Glaxo case involved accusations of criminal bribery to persuade hospitals and doctors to administer … don\\u0027t toy with me miss nagatoro season 3